DexCom revenue and financials

DXCM · NASDAQ · USD

$84.55−2.70%−$2.35

Close · October 6, 2026

In the fiscal year ended December 2025, DexCom reported revenue of $4.66B (+15.60% year over year). Net income was $836.3M, a net margin of 17.9%.

Annual revenue · 2025: $4.66B

Fiscal year ending in December. Sources and method on the page Methodology and sources.

At a glance

Amounts in millions of USD; per-share values in USD; shares in millions.

Income statement · Annual
Item	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Total revenue	4,662	4,033	3,622	2,910	2,449	1,927	1,476	1,032	719	573
Cost of revenue	1,860	1,595	1,333	1,027	768	647	545	368	226	195
Gross profit	2,802	2,438	2,289	1,883	1,681	1,280	932	664	492	378
Selling, general and administrative	1,291	1,286	1,185	1,008	—	—	—	—	—	—
Research and development	599	552	506	484	517	360	274	200	185	156
Operating income	912	600	598	391	266	300	142	-186	-42.5	-63.9
EBIT	1,107	728	731	409	—	—	—	—	—	—
EBITDA	1,359	946	917	565	—	—	—	—	—	—
Interest expense	18.3	19.0	20.3	18.6	18.8	17.7	60.3	22.7	12.8	0.7
Pre-tax income	1,088	709	710	391	—	—	—	—	—	—
Income tax	252	133	169	49.6	39.9	-252	3.1	0.6	1.6	0.7
Net income	836	576	542	341	217	550	101	-127	-50.2	-65.6
Net income to common shareholders	836	576	542	341	—	—	—	—	—	—
Basic EPS	2.14	1.46	1.40	0.88	0.56	1.46	1.11	-1.44	-0.58	—
Diluted EPS	2.09	1.42	1.30	0.82	0.53	1.33	1.10	-1.44	-0.58	—
Average shares (basic)	390	394	386	389	—	—	—	—	—	—
Average shares (diluted)	406	413	426	428	429	420	92.3	88.2	86.3	—